Zevra Therapeutics, Inc.ZVRANASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+72.8%
5Y CAGR+57.8%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+72.8%/yr
vs +4.7%/yr prior
5Y CAGR
+57.8%/yr
Recent acceleration
Acceleration
+68.1pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
9.8x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $77.62M | +41.5% |
| 2024 | $54.87M | +56.4% |
| 2023 | $35.09M | +133.3% |
| 2022 | $15.04M | +72.8% |
| 2021 | $8.70M | +9.8% |
| 2020 | $7.92M | -26.8% |
| 2019 | $10.82M | -13.5% |
| 2018 | $12.51M | -2.1% |
| 2017 | $12.77M | -8.8% |
| 2016 | $14.00M | - |